Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-04-21
1990-02-06
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544237, 546118, 546141, 546157, 546158, A61K 3147, C07D47104
Patent
active
048988723
ABSTRACT:
A series of novel heterobicyclic substituted 2-(1H)-quinolone compounds have been prepared, including the 3,4-dihydro derivatives thereof, wherein the heterobicyclic ring moiety is an optionally-substituted indolyl, phthalizinyl, benzimidazolyl, imidazopyridinyl, quinolinyl or isoquinolinyl group attached by an nitrogen or carbon atom of said group to the 6-position of the quinolone ring. The optional substituent is a C.sub.1 -C.sub.14 alkyl group located on either of the two heterobicyclic rings and/or an oxo group situated on the heterocyclic portion of said heterobicyclic ring system. These particular compounds are useful in therapy as cardiac stimulants and therefore, are of value in the treatment of various cardiac conditions. 6-{1(H)-Imidazo[4,5-b]pyridin-6-yl}-8-methyl-2-(1H)-quinolone represents a typical and preferred member compound. Methods for preparing these compounds from known starting materials are provided.
REFERENCES:
patent: 4710507 (1987-12-01), Campbell et al.
patent: 4728653 (1988-03-01), Campbell et al.
patent: 4728654 (1988-03-01), Campbell et al.
patent: 4740513 (1988-04-01), Campbell et al.
Campbell Simon F.
Morris David S.
Roberts David A.
Dentz Bernard I.
Ginsburg Paul H.
Lee Mary C.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Imidazo[4,5-b]pyridyl quinolone cardiac stimulants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazo[4,5-b]pyridyl quinolone cardiac stimulants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo[4,5-b]pyridyl quinolone cardiac stimulants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-442017